Angela Genge, MD, FRCP

Dr. Angela Genge is a professor and neurologist specializing in neuromuscular diseases, particularly ALS. She is the director of the Amyotrophic Lateral Sclerosis (ALS) Clinic at The Neuro at Montreal Neurological Institute-Hospital and the executive director of The ALS Center of Excellence. She earned her MD at Memorial University of Newfoundland, completed her residencies at McGill University, and completed a fellowship in neuromuscular diseases at The Neuro. She obtained her Canadian and American certifications in internal medicine and neurology.

During her tenure as executive director of the Clinical Research Unit (CRU) at The Neuro from 2004 to 2023, she established it as one of the largest neurological clinical research centers in Canada, home to a first-of-its-kind Phase 1 Unit dedicated to neurological diseases. As of January 2025, she has assumed the position of director of clinical research and the CIM at the MUHC Research Institute.

Recognized as an international leader in clinical trial design and an expert in rare neurological conditions, Dr. Genge has led trials in ALS, dementias, myopathies, neuropathies, myasthenia gravis, and pain. She has extensive experience in trial design and drug development, from early-phase trials to real-world evidence programs, as well as in regulatory and medical affairs. Dr. Genge has served as a consultant for biotechs in rare diseases and on numerous advisory boards and data and safety monitoring boards.

Her work and dedication have been acknowledged with multiple awards, including the 2023 Wings Over Wall Street Award, the 2018 Forbes Norris Award from the International Alliance for ALS/MND Associations, and the Governor General's Diamond Jubilee Award. She currently leads ACCESS ALS and sits on the executive committees for CAPTURE ALS, TRICALS, Precision ALS, the ALS Network, and the WFN MND study group.